Mitochondrial Antioxidant (mitochondrial + antioxidant)

Distribution by Scientific Domains


Selected Abstracts


Pituitary adenylate cyclase-activating polypeptide attenuates streptozotocin-induced apoptotic death of RIN-m5F cells through regulation of Bcl-2 family protein mRNA expression

FEBS JOURNAL, Issue 22 2008
Satomi Onoue
Oxidative stress, followed by the apoptotic death of pancreatic , cells, is considered to be one of causative agents in the evolution of the type 2 diabetic state; therefore, the protection of , cells can comprise an efficacious strategy for preventing type 2 diabetes. In the present study, RIN-m5F cells (i.e. the rat insulinoma , cell line) were stimulated with streptozotocin, resulting in a time- and concentration-dependent release of lactate dehydrogenase. There appeared to be significant apoptotic cell death after 2 h of treatment with streptozotocin at 10 mm, as demonstrated by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining and 2.6-fold activation of cellular caspase-3, an apoptotic enzyme. By contrast, some neuropeptides of the glucagon-secretin family and coenzyme Q10, an endogenous mitochondrial antioxidant, could attenuate streptozotocin cytotoxicity, and especially pituitary adenylate cyclase-activating polypeptide (PACAP), at a concentration of 10,7 m, exhibited 34% attenuation of lactate dehydrogenase release from streptozotocin-treated RIN-m5F cells. Quantitative RT-PCR experiments indicated the inhibitory effect of PACAP on streptozotocin-evoked up-regulation of pro-apoptotic factor (Noxa and Bax) and a 2.3-fold enhancement of Bcl-2 mRNA expression, a pro-survival protein, was also observed after addition of PACAP. The data obtained suggest the anti-apoptotic role of PACAP in streptozotocin-treated RIN-m5F cells through the regulation of pro-apoptotic and pro-survival factors. [source]


A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease

MOVEMENT DISORDERS, Issue 11 2010
Barry J. Snow MD
Abstract Multiple lines of evidence point to mitochondrial oxidative stress as a potential pathogenic cause for Parkinson's disease (PD). MitoQ is a powerful mitochondrial antioxidant. It is absorbed orally and concentrates within mitochondria where it has been shown to protect against oxidative damage. We enrolled 128 newly diagnosed untreated patients with PD in a double-blind study of two doses of MitoQ compared with placebo to explore the hypothesis that, over 12 months, MitoQ would slow the progression of PD as measured by clinical scores, particularly the Unified Parkinson Disease Rating Scale. We showed no difference between MitoQ and placebo on any measure of PD progression. MitoQ does not slow the progression of PD, and this finding should be taken into account when considering the oxidative stress hypothesis for the pathogenesis of PD. © 2010 Movement Disorder Society [source]


Combined R-,,lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, Issue 1-2 2010
Hongyu Zhang
Abstract Mitochondrial dysfunction and oxidative damage are highly involved in the pathogenesis of Parkinson's disease (PD). Some mitochondrial antioxidants/nutrients that can improve mitochondrial function and/or attenuate oxidative damage have been implicated in PD therapy. However, few studies have evaluated the preventative effects of a combination of mitochondrial antioxidants/nutrients against PD, and even fewer have sought to optimize the doses of the combined agents. The present study examined the preventative effects of two mitochondrial antioxidant/nutrients, R-,,lipoic acid (LA) and acetyl-L-carnitine (ALC), in a chronic rotenone-induced cellular model of PD. We demonstrated that 4-week pretreatment with LA and/or ALC effectively protected SK-N-MC human neuroblastoma cells against rotenone-induced mitochondrial dysfunction, oxidative damage and accumulation of ,-synuclein and ubiquitin. Most notably, we found that when combined, LA and ALC worked at 100,1000-fold lower concentrations than they did individually. We also found that pretreatment with combined LA and ALC increased mitochondrial biogenesis and decreased production of reactive oxygen species through the up-regulation of the peroxisome proliferator-activated receptor-, coactivator 1, as a possible underlying mechanism. This study provides important evidence that combining mitochondrial antioxidant/nutrients at optimal doses might be an effective and safe prevention strategy for PD. [source]


Comparison of mitochondrial ascorbate peroxidase in the cultivated tomato, Lycopersicon esculentum, and its wild, salt-tolerant relative, L. pennellii, a role for matrix isoforms in protection against oxidative damage

PLANT CELL & ENVIRONMENT, Issue 2 2004
V. MITTOVA
ABSTRACT Mitochondria require robust antioxidant defences to prevent lipid peroxidation and to protect tricarboxylic acid cycle enzymes from oxidative damage. Mitochondria from wild, salt-tolerant tomato, Lycopersicon pennellii (Lpa) did not exhibit lipid peroxidation in response to high salinity (100 mm NaCl), whereas those isolated from cultivated tomato, L. esculentum (Lem), accumulated malondialdehyde. The activity, intraorganellar distribution and salt response of mitochondrial ascorbate peroxidase (mAPX) differed dramatically in the two species. In Lem mitochondria, the majority (84%) of mAPX was associated with membranes, being located either on the inner membrane, facing the intermembrane space, or on the outer membrane. Total mAPX activity did not increase substantially in response to salt, although the proportion of matrix APX increased. In contrast, 61% of Lpa mAPX activity was soluble in the matrix, the remainder being bound to the matrix face of the inner membrane. Salt treatment increased the activity of all mAPX isoforms in Lpa, without altering their intramitochondrial distribution. The membrane-bound isoforms were detected in mitochondria of both species by western blotting and found to be induced by salt in Lpa. These observations suggest that matrix-associated APX isoforms could act in concert with other mitochondrial antioxidants to protect against salt-induced oxidative stress. [source]